Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
Authors:
- David J. MaronDMDavid J. Maron
- William E. BodenWBWilliam E. Boden
- John A. SpertusJSJohn A. Spertus
- Pamela M. HartiganPHPamela M. Hartigan
- G.B. John ManciniGMG.B. John Mancini
- Steven P. SedlisSSSteven P. Sedlis
- William J. KostukWKWilliam J. Kostuk
- Bernard R. ChaitmanBCBernard R. Chaitman
- Leslee J. ShawLSLeslee J. Shaw
- Daniel S. BermanDBDaniel S. Berman
- Marcin DadaMDMarcin Dada
- Koon K. TeoKTKoon K. Teo
Abstract
No abstract availableKeywords
Funding Information
- Merck
- Pfizer
- Bristol-Myers Squibb
- Fujisawa
- Kos Pharmaceuticals
- Datascope
- AstraZeneca
- Key Pharmaceutical
- Sanofi-Aventis
- First Horizon
- GE Healthcare
- Amgen
- Bristol-Myers Squibb
- Sanofi-Aventis
- Eli Lilly
- Johnson & Johnson
- Evaheart Medical
- Merck
This publication has 28 references indexed in Scilit:
- A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in TehranJournal of Epidemiology and Community Health, 2010
- Metabolic Syndrome and All-Cause and Cardiovascular Mortality in an Italian Elderly PopulationDiabetes Care, 2009
- Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II studyCoronary Artery Disease, 2008
- Metabolic Syndrome and Mortality in Older AdultsArchives of internal medicine (1960), 2008
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all‐cause mortality – results of prospective analysis for the Atherosclerosis Risk in Communities studyJournal of Internal Medicine, 2007
- Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) StudyHypertension, 2007
- Metabolic Syndrome and Early-Onset Coronary Artery DiseaseJACC, 2006
- Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trialAmerican Heart Journal, 2006
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001